Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-23
1999-10-12
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 424678, A61K 3800, C07K 500, C07K 700, A01N 5908
Patent
active
059655330
ABSTRACT:
The present invention provides a peritoneal dialysis solution that contains atrial natriuretic peptide (ANP), a derivative of ANP, an analogue of ANP, a substance that binds ANP to clearance receptors or a substance that promotes ANP synthesis, which results in an increased net ultrafiltration and increased sodium clearance experienced in peritoneal dialysis patients.
REFERENCES:
patent: 5258368 (1993-11-01), Lewicki et al.
patent: 5589197 (1996-12-01), Shockley et al.
patent: 5629025 (1997-05-01), Shockley et al.
patent: 5631025 (1997-05-01), Shockley et al.
Laffi et al., "Renal Hemodynamic and Natriuretic Effects of Human Atrial Natriuretic Factor Infusion in Cirrhosis With Ascites," Gastroenterology, vol. 96, Jan. 1989, pp. 167-177.
Bianciotti, L.G., et al.: "Atrial natiruretic factor increases peritoneal dialysis efficiency in nephrectomized rats." Peptides, (1996) 17 (1) 87-92, XP002081185, see the whole document.
Wang, T., et al.: "Atrial natriuretic factor increases peritoneal fluid removal." 15th Annual Meeting of the International Society of Blood Purification, Florence, Italy, Sep. 11-13, 1997. Blood Purification 15 (Suppl. 2), 1997, 4, XP002081186, see the whole document.
Wang, T. (Reprint), et al.: "Atrial natriuretic factor increases peritoneal fluid removal." Journal of the American Society of Nephrology, (Sep. 1997) vol. 8, Supp. S!, P 183A, XP002081187, see abstract AO856.
Teitze et al. "Renal haemodynamic changes, renal tubular function, sodium and water homeostatic hormones in patients with chronic glomerulonephritis and in healthy humans after intravenous infusion of amino acids", Nephrol Dial Transplant (England), 1994, vol. 9, pp. 499-504.
Eiskjaer et al., "Dose-response study of atrial natriuretic peptide bolus injection in healthy man", Eur. J Clim Invest (England), vol. 23, Jan. 1993, pp. 37-45.
Trevisan, et al., "Effects of atrial natriuretic peptide infusion on kidney function in normotensive type 1 (insulin dependent) diabetic patients before and after enalapril treatment", J Hypertens Suppl (England), vol. 9, Dec. 1991, pp. 390-391.
Predel, et al., "Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses", Am J. Hypertens (United States), vol. 4, Nov. 1991, pp. 871-879.
Hirata, et al., "Nephrogenous cyclic GMP production during NaCl loading and ANP infusion", Jpn Heart J (Japan), vol. 31, Nov. 1990, pp. 809-816.
Gaillard, et al., "Renal response to infusion versus repeated bolus injections of atrial natriuretic factor in man", Eur J Clin Pharmacol (Germany, West), vol. 36, 1989, pp. 195-197.
Laffi et al., "Renal hemodyamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites", Gastroenterology (United States), vol. 96, Jan. 1989, pp. 167-177.
Cottier, et al., "Renal response to low-dose infusion of atrial natriuretic peptide in normal man", Kidney Int Suppl (United States), vol. 25, Sep. 1988, pp. 72-78.
Biollaz, et al., "Site of the action of a synthetic atrial natriuretic peptide evaluated in humans", Kidney Int (United States), vol. 32, Oct. 1987, pp. 537-546.
Chen Chi J.
Johnston Miles G.
Shockley Ty R.
Barrett Robert M.
Baxter International Inc.
Borecki Thomas S.
Davenport Avis M.
Johnston Miles G.
LandOfFree
Atrial natriuretic peptide (ANP) as an additive to peritoneal di does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Atrial natriuretic peptide (ANP) as an additive to peritoneal di, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atrial natriuretic peptide (ANP) as an additive to peritoneal di will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652443